Patient-Reported Outcomes in Psoriatic Arthritis

Ana-Maria Orbai, Alexis Ogdie

Research output: Contribution to journalArticle


Patient-reported outcome (PRO) measures are an important component to assessing disease impact and therapy response in patients with psoriatic arthritis (PsA). Overall, there are few PsA-specific PROs. Most PROs used in PsA are borrowed from other diseases (eg, rheumatoid arthritis and ankylosing spondylitis) or general population PROs. PROs are used in PsA clinical trials and in the clinical management of PsA. In this review, we discuss the most commonly used PRO in PsA, including their inclusion in composite measures. Future studies may be helpful to determine the best performing PROs in patients with PsA.

Original languageEnglish (US)
JournalRheumatic Disease Clinics of North America
StateAccepted/In press - 2016



  • Composite measures
  • Outcome measure
  • Patient reported outcome
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this